Ribosome-Binding Site (RBS)
Characterization of cscB: pAM2991
pAM2991 is an IPTG-inducible vector, designed for overexpression of a gene inserted into the multiple cloning site. pAM2291 (as well as the other backbone plasmids) can be found on addgene under the Golden Lab. The smR gene confers resistance to two antibiotics: streptomycin and spectinomycin. We selected for the vector in cultures using spectinomycin in DH10-beta competent E. coli (this strain is naturally resistance to streptomycin) and both streptomycin and spectinomycin in our cyanobacteria. Additionally, we linearized this vector by cutting with both BamHI and EcoRI; by cutting with two enzymes, we minimized the chance for spontaneous re-ligation. We used this vector to characterize our sucrose symporter BioBrick, cscB. We also used this vector in an attempt to improve the enhanced yellow fluorescent protein (EYFP) BioBrick by codon optimization; unfortunately, we could not collect data on this BioBrick.
This vector is a suicide vector with neutral site II (NSII). In cyanobacteria, there are stretches of DNA in their genomes called neutral sites, which can be replaced with other DN without any detriment to the cell. Our “suicide vector” is composed of DNA that identically matches the neutral sites found in cyanobacteria. Our genes of interest and antibiotic resistance genes are flanked on both sides by the neutral site DNA (>300 bp on both sides). When our plasmid enters cells (it does this because the cells are naturally competent), the identical strands of DNA undergo a double homologous recombination event, and the DNA from the plasmid is integrated into the genome of the cyanobacteria. In the plasmid, there is no origin of replication for cyanobacteria, so this mechanism is the only way in which the exogenous DNA enters the cell. We screen colonies with antibiotics to ensure this event has taken place.
Characterization of Novel Promoters: pAM1414
pAM1414 is a promoterless luxAB reporter plasmid, designed for promoters inserted upstream of luxA to express both luxA and luxB. The luxAB bioreporter generates a light signal in the presence of decanal. The smR gene confers resistance to two antibiotics: streptomycin and spectinomycin. We selected for the vector in cultures using spectinomycin in HB101 competent E. coli and both streptomycin and spectinomycin in our cyanobacteria. We linearized this vector by digestion with BamHI and prevented re-linearization by dephosphorylation with calf intestinal phosphatase (CIP). We used this vector to characterize our novel promoters: cpc, cpc-560, idiA, and psbA2.
This vector is a suicide vector with neutral site I (NSI), and works in the same way as pAM2991.
Application of Novel Promoters: pAM1579
pAM1579 is another suicide vector lacking promoters and genes. It does have terminators, but after correspondence with McKenna Hicks, a member from the 2017 UCSC iGEM Team who worked with this vector, we realized that the terminators were oriented in the wrong direction. Therefore, we incorporated these terminators into the constructs for this part of the project. The KanR gene confers resistance to the antibiotics, kanamycin. Therefore, we selected for the vector in both DH10-beta competent E. coli and our cyanobacteria using kanamycin. We linearized this vector by cutting with both EcoRV and SalI; by cutting with two enzymes, we minimized the chance for spontaneous re-ligation. We intended to use this vector to characterize circuits pairing our novel promoters, psbA2 and idiA, with our sucrose genes, cscB and sps (sps did not get characterized in pAM2991 due to DNA synthesis issues but is referenced on the Project Description page).
This vector is a suicide vector with neutral site II (NSII), and works in the same way as pAM2991.